Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Apria, Inc.
  6. News
  7. Summary
    APR   US03836A1016

APRIA, INC.

(APR)
  Report
Delayed Quote. Delayed Nasdaq - 12/08 04:00:00 pm
31.37 USD   -0.19%
12/08INSIDER SELL : Apria
MT
11/15Apria Completes Secondary Offering of Common Stock
AQ
11/11Apria Prices Secondary Offering of 4.5 Million Shares
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Apria to Announce Third Quarter 2021 Financial Results

10/21/2021 | 08:01am EST

INDIANAPOLIS, Oct. 21, 2021 (GLOBE NEWSWIRE) -- Apria, Inc. (the “Company” or “Apria”) (Nasdaq: APR) announced today that it will release fiscal third quarter 2021 financial results on Thursday, November 4, 2021 after the market closes. In conjunction, the company will host a conference call to review results at 5:00 p.m. (ET) on the same day.

Conference Call Details

The conference call can be accessed by dialing (833) 362-0207 for U.S. participants, or (914) 987-7676 for international participants, referencing conference ID 4161279; or via a live audio webcast that will be available online at https://ir.apria.com/.

A replay of the call will be available via webcast for on-demand listening shortly after the completion of the call, at the same web link, and will remain available for approximately 90 days.

About Apria

Apria is a leading provider of integrated home healthcare equipment and related services in the United States, providing home respiratory therapy, obstructive sleep apnea treatment and negative pressure wound therapy. Its approximately 275 locations throughout the continental United States and Hawaii serve nearly 2 million patients each year. All of Apria’s locations are accredited by The Joint Commission.             

Investor Contacts
Kevin.Ellich@westwicke.com

Media Contacts
Mark.Corbae@westwicke.com 
Kyle.Evans@westwicke.com 

 


Primary Logo


ę GlobeNewswire 2021
All news about APRIA, INC.
12/08INSIDER SELL : Apria
MT
11/15Apria Completes Secondary Offering of Common Stock
AQ
11/11Apria Prices Secondary Offering of 4.5 Million Shares
MT
11/11Apria Announces Pricing of Secondary Offering of Common Stock
GL
11/11Apria Announces Pricing of Secondary Offering of Common Stock
GL
11/09Apria Launches Secondary Offering of 4.5 Million Common Shares
MT
11/08Apria Announces Launch of Secondary Offering of Common Stock
AQ
11/08Citigroup Reinstates Coverage of Apria at Buy with $43 Price Target
MT
11/05UBS Adjusts Price Target on Apria to $41 From $37, Maintains Buy Rating
MT
11/05APRIA, INC. Management's Discussion and Analysis of Financial Condition and Results of..
AQ
More news
Analyst Recommendations on APRIA, INC.
More recommendations
Financials (USD)
Sales 2021 1 141 M - -
Net income 2021 66,5 M - -
Net Debt 2021 271 M - -
P/E ratio 2021 18,7x
Yield 2021 -
Capitalization 1 113 M 1 113 M -
EV / Sales 2021 1,21x
EV / Sales 2022 1,09x
Nbr of Employees 6 290
Free-Float 97,4%
Chart APRIA, INC.
Duration : Period :
Apria, Inc. Technical Analysis Chart | APR | US03836A1016 | MarketScreener
Technical analysis trends APRIA, INC.
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 4
Last Close Price 31,37 $
Average target price 38,75 $
Spread / Average Target 23,5%
EPS Revisions
Managers and Directors
Daniel J. Starck Chief Executive Officer & Director
Debra L. Morris Chief Financial Officer& Executive Vice President
John G. Figueroa Chairman
Mark Litkovitz Chief Information Officer & Executive VP
Teresa L. Kline Independent Director
Sector and Competitors
1st jan.Capi. (M$)
APRIA, INC.0.00%1 113
ABBOTT LABORATORIES20.90%234 157
MEDTRONIC PLC-4.03%150 954
BECTON, DICKINSON AND COMPANY-1.51%71 108
HOYA CORPORATION29.61%58 237
DEXCOM, INC.52.78%54 121